Inhibition of tumour metastasis by targeted delivery of antioxidant enzymes

Expert Opinion on Drug Delivery

Volumn 3, Issue 3, 2006, Pages 355-369

  Nishikawa, Makiya ^a   Hashida, Mitsuru ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Catalase; Chemical modification; Luciferase; Metastasis; Reactive oxygen species; Targeted delivery

Indexed keywords

ANTIOXIDANT; ASPARAGINASE MACROGOL; BLEOMYCIN; CATALASE; CISPLATIN; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR; HORSERADISH PEROXIDASE; HYDROGEN PEROXIDE; HYPOXANTHINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MACROGOL; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE; PEGINTERFERON ALPHA2A; PROTEIN C FOS; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR FOSB; VASCULOTROPIN; XANTHINE OXIDASE;

ANTIOXIDANT ACTIVITY; ARTHRITIS; CANCER INHIBITION; CELL PROLIFERATION; CHEMICAL MODIFICATION; COLORECTAL CARCINOMA; CYTOTOXICITY; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG HALF LIFE; DRUG TARGETING; GENE EXPRESSION; GENETIC TRANSCRIPTION; GLYCOSYLATION; HEPATITIS C; HUMAN; LIVER METASTASIS; LUNG METASTASIS; MACROMOLECULE; MELANOMA; METASTASIS; METASTASIS INHIBITION; NONHUMAN; REVIEW; SECOND MESSENGER; SOLID TUMOR;

ANIMALS; CATALASE; DRUG DELIVERY SYSTEMS; HUMANS; HYDROGEN PEROXIDE; NEOPLASM METASTASIS; NEOPLASMS; OXIDOREDUCTASES; REACTIVE OXYGEN SPECIES;

EID: 33646843717     PISSN: 17425247     EISSN: None     Source Type: Journal    
DOI: 10.1517/17425247.3.3.355     Document Type: Review

References (103)

1. ENGERS R, GABBERT HE: Mechanisms of tumor metastasis: cell biological aspects and clinical implications. J. Cancer Res. Clin. Oncol. (2000) 126(12):682-692.
2. NISHIKAWA M, HYOUDOU K, KOBAYASHI Y, UMEYAMA Y, TAKAKURA Y, HASHIDA M: Inhibition of metastatic tumour growth by targeted delivery of antioxidant enzymes. J. Control. Release (2005) 109(1-3):101-107.
3. ZETTER BR: The cellular basis of site-specific tumor metastasis. N. Engl. J. Med. (1990) 322(9):605-612.
4. TANG DG, HONN KV: Adhesion molecules and tumor metastasis: an update. Invasion Metastasis (1994-1995) 14(1-6):109-122.
5. LI C, JACKSON RM: Reactive species mechanisms of cellular hypoxia-reoxygenation injury. Am. J. Physiol. (2002) 282(2):C227-C241.
6. BARBERA-GUILLEM E, WEISS L: Cancer-cell traffic in the liver. III. Lethal deformation of B16 melanoma cells in liver sinusoids. Int. J. Cancer (1993) 54(5):880-884.
7. JESSUP JM, BATTLE P, WALLER H et al.: Reactive nitrogen and oxygen radicals formed during hepatic ischemia-reperfusion kill weakly metastatic colorectal cancer cells. Cancer Res. (1999) 59(8):1825-1829.
8. WANG HH, MCINTOSH AR, HASINOFF BB et al.: B16 melanoma cell arrest in the mouse liver induces nitric oxide release and sinusoidal cytotoxicity: a natural hepatic defense against metastasis. Cancer Res. (2000) 60(20):5862-5869.
9. LAURENT A, NICCO C, CHEREAU C et al.: Controlling tumor growth by modulating endogenous production of reactive oxygen species. Cancer Res. (2005) 65(3):948-956.
10. SZATROWSKI TP, NATHAN CF: Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res. (1991) 51(3):794-798.
11. TOYOKUNI S: Oxidative stress and cancer: the role of redox regulation. Biotherapy (1998) 11(2-3):147-154.
12. BEHREND L, HENDERSON G, ZWACKA RM: Reactive oxygen species in oncogenic transformation. Biochem. Soc. Trans. (2003) 31(6):1441-1444.
13. CROSS AR, JONES OT: Enzymic mechanisms of superoxide production. Biochim. Biophys. Acta (1991) 1057(3):281-298.
14. BURDON RH: Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Radic. Biol. Med. (1995) 18(4):775-794.
15. MYTAR B, SIEDLAR M, WOLOSZYN M, RUGGIERO I, PRYJMA J, ZEMBALA M: Induction of reactive oxygen intermediates in human monocytes by tumour cells and their role in spontaneous monocyte cytotoxicity. Br. J. Cancer (1999) 79(5-6):737-743.
16. MEIER B, RADEKE HH, SELLE S et al.: Human fibroblasts release reactive oxygen species in response to interleukin-1 or tumour necrosis factor-α. Biochem. J. (1989) 263(2):539-545.
17. SCHRAUFSTATTER IU, HYSLOP PA, HINSHAW DB, SPRAGG RG, SKLAR LA, COCHRANE CG: Hydrogen peroxide-induced injury of cells and its prevention by inhibitors of poly(ADP-ribose) polymerase. Proc. Natl. Acad. Sci. USA (1986) 83(13):4908-4912.
18. HYOUDOU K, NISHIKAWA M, UMEYAMA Y, KOBAYASHI Y, YAMASHITA F, HASHIDA M: Inhibition of metastatic tumor growth in mouse lung by repeated administration of polyethylene glycol-conjugated catalase: quantitative analysis with firefly luciferase-expressing melanoma cells. Clin. Cancer. Res. (2004) 10(22):7685-7691.
19. PELICANO H, CARNEY D, HUANG P: ROS stress in cancer cells and therapeutic implications. Drug. Resist. Updat. (2004) 7(2):97-110.
20. CHAN WH, YU JS: Inhibition of UV irradiation-induced oxidative stress and apoptotic biochemical changes in human epidermal carcinoma A431 cells by genistein. J. Cell. Biochem. (2000) 78(1):73-84.
21. SERRANO J, PALMEIRA CM, KUEHL DW, WALLACE KB: Cardioselective and cumulative oxidation of mitochondrial DNA following subchronic doxorubicin administration. Biochim. Biophys. Acta (1999) 1411(1):201-205.
22. HUG H, STRAND S, GRAMBIHLER A et al.: Reactive oxygen intermediates are involved in the induction of CD95 ligand mRNA expression by cytostatic drugs in hepatoma cells. J. Biol. Chem. (1997) 272(45):28191-28193.
23. MIYAJIMA A, NAKASHIMA J, YOSHIOKA K, TACHIBANA M, TAZAKI H, MURAI M: Role of reactive oxygen species in cis-dichlorodiammineplatinum-induced cytotoxicity on bladder cancer cells. Br. J. Cancer (1997) 76(2):206-210.
24. SAWA T, WU J, AKAIKE T, MAEDA H: Tumor-targeting chemotherapy by a xanthine oxidase-polymer conjugate that generates oxygen-free radicals in tumor tissue. Cancer Res. (2000) 60(3):666-671.
25. SEN CK, PACKER L: Antioxidant and redox regulation of gene transcription. FASEB J. (1996) 10(7):709-720.
26. SUN Y, OBERLEY LW: Redox regulation of transcriptional activators. Free Radic. Biol. Med. (1996) 21(3):335-348.
27. ALLEN RG, TRESINI M: Oxidative stress and gene regulation. Free Radic. Biol. Med. (2000) 28(3):463-499.
28. SHAUGHNESSY SG, WHALEY M, LAFRENIE RM, ORR FW: Walker 256 tumor cell degradation of extracellular matrices involves a latent gelatinase activated by reactive oxygen species. Arch. Biochem. Biophys. (1993) 304(2):314-321.
29. 2 exposure. Lab. Invest. (1997) 77(5):533-539.
30. SELLAK H, FRANZINI E, HAKIM J, PASQUIER C: Reactive oxygen species rapidly increase endothelial ICAM-1 ability to bind neutrophils without detectable upregulation. Blood (1994) 83(9):2669-2677.
31. KNEBEL A, RAHMSDORF HJ, ULLRICH A, HERRLICH P: Dephosphorylation of receptor tyrosine kinases as target of regulation by radiation, oxidants or alkylating agents. EMBO J. (1996) 15(19):5314-5325.
32. 2 in rat heart endothelial cells. Free Radic. Biol. Med. (1998) 25(8):891-897.
33. NELSON KK, RANGANATHAN AC, MANSOURI J et al.: Elevated Sod2 activity augments matrix metalloproteinase expression: evidence for the involvement of endogenous hydrogen peroxide in regulating metastasis. Clin. Cancer Res. (2003) 9(1):424-432.
34. CHENG GC, SCHULZE PC, LEE RT, SYLVAN J, ZETTER BR, HUANG H: Oxidative stress and thioredoxin-interacting protein promote intravasation of melanoma cells. Exp. Cell Res. (2004) 300(2):297-307.
35. 2 for platelet-derived growth factor signal transduction. Science (1995) 270(5234):296-299.
36. ARNOLD RS, SHI J, MURAD E et al.: Hydrogen peroxide mediates the cell growth and transformation caused by the mitogenic oxidase Nox1. Proc. Natl. Acad. Sci. USA (2001) 98(10):5550-5555.
37. YABE Y, KOYAMA Y, NISHIKAWA M, TAKAKURA Y, HASHIDA M: Hepatocyte-specific distribution of catalase and its inhibitory effect on hepatic ischemia/reperfusion injury in mice. Free Radic. Res. (1999) 30(4):265-274.
38. TAKAKURA Y, FUJITA T, HASHIDA M, SEZAKI H: Disposition characteristics of macromolecules in tumor-bearing mice. Pharm. Res. (1990) 7(4):339-346.
39. SEYMOUR LW, MIYAMOTO Y, MAEDA H et al.: Influence of molecular weight on passive tumour accumulation of a soluble macromolecular drug carrier. Eur. J. Cancer (1995) 31A(5):766-770.
40. YABE Y, NISHIKAWA M, TAMADA A, TAKAKURA Y, HASHIDA M: Targeted delivery and improved therapeutic potential of catalase by chemical modification: combination with superoxide dismutase derivatives. J. Pharmacol. Exp. Ther. (1999) 289(2):1176-1184.
41. NARA E, MASEGI M, HATONO T, HASHIDA M: Pharmacokinetic analysis of drug absorption from muscle based on a physiological diffusion model: effect of molecular size on absorption. Pharm. Res. (1992) 9(2):161-168.
42. NOMURA T, NAKAJIMA S, KAWABATA K, YAMASHITA F, TAKAKURA Y, HASHIDA M: Intratumoral pharmacokinetics and in vivo gene expression of naked plasmid DNA and its cationic liposome complexes after direct gene transfer. Cancer Res. (1997) 57(13):2681-2686.
43. NOMURA T, SAIKAWA A, MORITA S et al.: Pharmacokinetic characteristics and therapeutic effects of mitomycin C-dextran conjugates after intratumoural injection. J. Control. Release (1998) 52(3):239-252.
44. SEZAKI H, HASHIDA M: Macromolecule-drug conjugates in targeted cancer chemotherapy. Crit. Rev. Ther. Drug Carrier Syst. (1984) 1(1):1-38.
45. SIMIONESCU N: Cellular aspects of transcapillary exchange. Physiol. Rev. (1983) 63(4):1536-1579.
46. MATSUMURA Y, MAEDA H: A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res. (1986) 46(12 Pt 1):6387-6392.
47. BRENNER BM, HOSTETTER TH, HUMES HD: Glomerular permselectivity: barrier function based on discrimination of molecular size and charge. Am. J. Physiol. (1978) 234(6):F455-F460.
48. NISHIKAWA M, HIRABAYASHI H, TAKAKURA Y, HASHIDA M: Design for cell-specific targeting of proteins utilizing sugar-recognition mechanism: effect of molecular weight of proteins on targeting efficiency. Pharm. Res. (1995) 12(2):209-214.
49. MIHARA K, HOJO T, FUJIKAWA M, TAKAKURA Y, SEZAKI H, HASHIDA M: Disposition characteristics of protein drugs in the perfused rat kidney. Pharm. Res. (1993) 10(6):823-827.
50. MIYAZAKI A, NAKAYAMA H, HORIUCHI S: Scavenger receptors that recognize advanced glycation end products. Trends Cardiovasc. Med. (2002) 12(6):258-262.
51. YAMASAKI Y, SUMIMOTO K, NISHIKAWA M et al.: Pharmacokinetic analysis of in vivo disposition of succinylated proteins targeted to liver nonparenchymal cells via scavenger receptors: importance of molecular size and negative charge density for in vivo recognition by receptors. J. Pharmacol. Exp. Ther. (2002) 301(2):467-477.
52. TAKAKURA Y, MAHATO RI, HASHIDA M: Extravasation of macromolecules. Adv. Drug Deliv. Rev. (1998) 34(1):93-108.
53. RAPOPORT SI: Osmotic opening of the blood-brain barrier: principles, mechanism, and therapeutic applications. Cell. Mol. Neurobiol. (2000) 20(2):217-230.
54. LIU F, SONG Y, LIU D: Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther. (1999) 6(7):1258-1266.
55. KOBAYASHI N, NISHIKAWA M, TAKAKURA Y: The hydrodynamics-based procedure for controlling the pharmacokinetics of gene medicines at whole body, organ and cellular levels. Adv. Drug Deliv. Rev. (2005) 57(5):713-731.
56. KOBAYASHI N, NISHIKAWA M, HIRATA K, TAKAKURA Y: Hydrodynamics-based procedure involves transient hyperpermeability in the hepatic cellular membrane: implication of a nonspecific process in efficient intracellular gene delivery. J. Gene Med. (2004) 6(5):584-592.
57. ZHANG G, GAO X, SONG YK et al.: Hydroporation as the mechanism of hydrodynamic delivery. Gene Ther. (2004) 11(8):675-682.
58. LIANG KW, NISHIKAWA M, LIU F, SUN B, YE Q, HUANG L: Restoration of dystrophin expression in mdx mice by intravascular injection of naked DNA containing full-length dystrophin cDNA. Gene Ther. (2004) 11(11):901-908.
59. SEZAKI H, TAKAKURA Y, HASHIDA M: Soluble macromolecular carriers for the delivery of antitumor drugs. Adv. Drug Deliv. Rev. (1989) 3:247-266.
60. NISHIKAWA M, TAKAKURA Y, HASHIDA M: Theoretical considerations involving the pharmacokinetics of plasmid DNA. Adv. Drug Deliv. Rev. (2005) 57(5):675-688.
61. ROBERTS MJ, BENTLEY MD, HARRIS JM: Chemistry for peptide and protein PEGylation. Adv. Drug Deliv. Rev. (2002) 54(4):459-476.
62. VERONESE FM, CALICETI P, SCHIAVON O, SERGI M: Polyethylene glycol-superoxide dismutase, a conjugate in search of exploitation. Adv. Drug Deliv. Rev. (2002) 54(4):587-606.
63. GREGORIADIS G, MCCORMACK B, WANG Z, LIFELY R: Polysialic acids: potential in drug delivery. FEBS Lett. (1993) 315(3):271-276.
64. OGINO T, INOUE M, ANDO Y, AWAI M, MAEDA H, MORINO Y: Chemical modification of superoxide dismutase. Extension of plasma half life of the enzyme through its reversible binding to the circulating albumin. Int. J. Pept. Protein Res. (1988) 32(2):153-159.
65. MAEDA H, WU J, SAWA T, MATSUMURA Y, HORI K: Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J. Control. Release (2000) 65(1-2):271-284.
66. TRIGUERO D, BUCIAK JB, YANG J, PARDRIDGE WM: Blood-brain barrier transport of cationized immunoglobulin G: enhanced delivery compared to native protein. Proc. Natl. Acad. Sci. USA (1989) 86(12):4761-4765.
67. NISHIKAWA M, HASEGAWA S, YAMASHITA F, TAKAKURA Y, HASHIDA M: Electrical charge on protein regulates its absorption from the rat small intestine. Am. J. Physiol. (2002) 282(4):G711-G719.
68. OPANASOPIT P, NISHIKAWA M, HASHIDA M: Factors affecting drug and gene delivery: effects of interaction with blood components. Crit. Rev. Ther. Drug Carrier Syst. (2002) 19(3):191-233.
69. MA SF, NISHIKAWA M, KATSUMI H, YAMASHITA F, HASHIDA M: Cationic charge-dependent hepatic delivery of amidated serum albumin. J. Control. Release (2005) 102(3):583-594.
70. MIHARA K, OKAY, SAWAI K, TAKAKURA Y, HASHIDA M: Improvement of therapeutic effect of human recombinant superoxide dismutase on ischemic acute renal failure in the rat via cationization and conjugation with polyethylene glycol. J. Drug Target. (1994) 2(4):317-321.
71. SCHALKWIJK J, VAN DEN BERG WB, VAN DE PUTTE LB, JOOSTEN LA, VAN DEN BERSSELAAR L: Cationization of catalase, peroxidase, and superoxide dismutase. Effect of improved intraarticular retention on experimental arthritis in mice. J. Clin. Invest. (1985) 76(1):198-205.
72. MORELL AG, GREGORIADIS G, SCHEINBERG IH, HICKMAN J, ASHWELL G: The role of sialic acid in determining the survival of glycoproteins in the circulation. J. Biol. Chem. (1971) 246(5):1461-1467.
73. ROGERS JC, KORNFELD S: Hepatic uptake of proteins coupled to fetuin glycopeptide. Biochem. Biophys. Res. Commun. (1971) 45(3):622-629.
74. CONNOLLY DT, TOWNSEND RR, KAWAGUCHI K, BELL WR, LEE YC: Binding and endocytosis of cluster glycosides by rabbit hepatocytes. Evidence for a short-circuit pathway that does not lead to degradation. J. Biol. Chem. (1982) 257(2):939-945.
75. NISHIKAWA M, OHTSUBO Y, OHNO J et al.: Pharmacokinetics of receptor-mediated hepatic uptake of glycosylated albumin in mice. Int. J. Pharm. (1992) 85(1):75-85.
76. NISHIKAWA M, MIYAZAKI C, YAMASHITA F, TAKAKURA Y, HASHIDA M: Galactosylated proteins are recognized by the liver according to the surface density of galactose moieties. Am. J. Physiol. (1995) 268(5 Pt 1):G849-G856.
77. OPANASOPIT P, SHIRAISHI K, NISHIKAWA M, YAMASHITA F, TAKAKURA Y, HASHIDA M: In vivo recognition of mannosylated proteins by hepatic mannose receptors and mannan-binding protein. Am. J. Physiol. (2001) 280(5):G879-G889.
78. SETT R, SARKAR HS, DAS PK: Pharmacokinetics and biodistribution of methotrexate conjugated to mannosyl human serum albumin. J. Antimicrob. Chemother. (1993) 31(1):151-159.
79. YABE Y, KOBAYASHI N, NISHIHASHI T et al.: Prevention of neutrophil-mediated hepatic ischemia/reperfusion injury by superoxide dismutase and catalase derivatives. J. Pharmacol. Exp. Ther. (2001) 298(3):894-899.
80. JANSEN RW, MOLEMA G, CHING TL et al.: Hepatic endocytosis of various types of mannose-terminated albumins. What is important, sugar recognition, net charge, or the combination of these features. J. Biol. Chem. (1991) 266(5):3343-3348.
81. TERPSTRA V, VAN AMERSFOORT ES, VAN VELZEN AG, KUIPER J, VAN BERKEL TJ: Hepatic and extrahepatic scavenger receptors: function in relation to disease. Arterioscler. Thromb. Vasc. Biol. (2000) 20(8):1860-1872.
82. KOHLER C, MILSTEIN C: Continuous cultures of fused cells secreting antibody of predefined specificity. Nature (1975) 256(5517):495-497.
83. KOZOWER BD, CHRISTOFIDOU-SOLOMIDOU M, SWEITZER TD et al.: Immunotargeting of catalase to the pulmonary endothelium alleviates oxidative stress and reduces acute lung transplantation injury. Nat. Biotechnol. (2003) 21(4):392-398.
84. NONAKA Y, IWAGAKI H, KIMURA T, FUCHIMOTO S, ORITA K: Effect of reactive oxygen intermediates on the in vitro invasive capacity of tumor cells and liver metastasis in mice. Int. J. Cancer (1993) 54(6):983-986.
85. SAFFORD SE, OBERLEY TD, URANO M, ST CLAIR DK: Suppression of fibrosarcoma metastasis by elevated expression of manganese superoxide dismutase. Cancer Res. (1994) 54(16):4261-4265.
86. KOGAWA K, MURAMATSU H, TANAKA M et al.: Enhanced inhibition of experimental metastasis by the combination chemotherapy of Cu-Zn SOD and adriamycin. Clin. Exp. Metastasis (1999) 17(3):239-244.
87. TAKENAGA M, IGARASHI R, OCHIAI A, MIZUSHIMA Y: Effect of lecithinized superoxide dismutase (PC-SOD) on experimental pulmonary metastasis in mice. Free Radic. Biol. Med. (1999) 26(9-10):1117-1125.
88. VAN ROSSEN ME, SLUITER W, BONTHUIS F, JEEKEL H, MARQUET RL, VAN EIJCK CH: Scavenging of reactive oxygen species leads to diminished peritoneal tumor recurrence. Cancer Res. (2000) 60(20):5625-5629.
89. NISHIKAWA M, TAMADA A, HYOUDOU K et al.: Inhibition of experimental hepatic metastasis by targeted delivery of catalase in mice. Clin. Exp. Metastasis (2004) 21(3):213-221.
90. BAYON LG, IZQUIERDO MA, SIROVICH I, VAN ROOIJEN N, BEELEN RH, MEIJER S: Role of Kupffer cells in arresting circulating tumor cells and controlling metastatic growth in the liver. Hepatology (1996) 23(5):1224-1231.
91. RUSHFELDT C, SVEINBJORNSSON B, SELJELID R, SMEDSROD B: Early events of hepatic metastasis formation in mice: role of Kupffer and NK-cells in natural and interferon-γ-stimulated defense. J. Surg. Res. (1999) 82(2):209-215.
92. WENK J, BRENNEISEN P, WLASCHEK M et al.: Stable overexpression of manganese superoxide dismutase in mitochondria identifies hydrogen peroxide as a major oxidant in the AP-1-mediated induction of matrix-degrading metalloprotease-1. J. Biol. Chem. (1999) 274(36):25869-25876.
93. NISHIKAWA M, TAMADA A, KUMAI H, YAMASHITA F, HASHIDA M: Inhibition of experimental pulmonary metastasis by controlling biodistribution of catalase in mice. Int. J. Cancer (2002) 99(3):474-479.
94. ZHANG L, HELLSTROM KE, CHEN L: Luciferase activity as a marker of tumor burden and as an indicator of tumor response to antineoplastic therapy in vivo. Clin. Exp. Metastasis (1994) 12(2):87-92.
95. VOOIJS M, JONKERS J, LYONS S, BERNS A: Noninvasive imaging of spontaneous retinoblastoma pathway-dependent tumors in mice. Cancer Res. (2002) 62(6):1862-1867.
96. RAY P, WU AM, GAMBHIR SS: Optical bioluminescence and positron emission tomography imaging of a novel fusion reporter gene in tumor xenografts of living mice. Cancer Res. (2003) 63(6):1160-1165.
97. DEMICHELI R, ABBATTISTA A, MICELI R, VALAGUSSA P, BONADONNA G: Time distribution of the recurrence risk for breast cancer patients undergoing mastectomy: further support about the concept of tumor dormancy. Breast Cancer Res. Treat. (1996) 41(2):177-185.
98. GOODISON S, KAWAI K, HIHARA J et al.: Prolonged dormancy and site-specific growth potential of cancer cells spontaneously disseminated from nonmetastatic breast tumors as revealed by labeling with green fluorescent protein. Clin. Cancer Res. (2003) 9(10 Pt 1):3808-3814.
99. MORRIS VL, KOOP S, MACDONALD IC et al.: Mammary carcinoma cell lines of high and low metastatic potential differ not in extravasation but in subsequent migration and growth. Clin. Exp. Metastasis (1994) 12(6):357-367.
100. CAMERON MD, SCHMIDT EE, KERKVLIET N et al.: Temporal progression of metastasis in lung: cell survival, dormancy, and location dependence of metastatic inefficiency. Cancer Res. (2000) 60(9):2541-2546.
101. BOUVY ND, MARQUET RL, JEEKEL J, BONJER HJ: Laparoscopic surgery is associated with less tumour growth stimulation than conventional surgery: an experimental study. Br. J. Surg. (1997) 84(3):358-361.
102. VAN DEN TOL PM, VAN ROSSEN EE, VAN EIJCK CH, BONTHUIS F, MARQUET RL, JEEKEL H: Reduction of peritoneal trauma by using nonsurgical gauze leads to less implantation metastasis of spilled tumor cells. Ann. Surg. (1998) 227(2):242-248.
103. MATOBA T, SHIMOKAWA H, NAKASHIMA M et al.: Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice. J. Clin. Invest. (2000) 106(12):1521-1530.